혹시 part data pt(으)로 찾으셨나요?

블로그

• A phase 1b/2, open-label study of adrixetinib (Q702) in combination with intravenous pembrolizumab -1/PD-L1 treatment. The Part 1 dose....... blog.naver.com · 2025.06.03